Newborn screening testing is the practice of testing newborn children for certain fatal diseases that are not evident at birth. It was started by scientist Robert Guthrie in 1960s when he developed a test to check for the metabolic disorder called phenylketonuria. A simple blood test is conducted after birth which reveals the conditions that could eventually develop into chronic illnesses. Diseases diagnosed in the newborn screening test are phenylketonuria,congenital hypothyroidism, galactosemia, sickle cell disease, biotinidase deficiency, congenital adrenal hyperplasia, maple syrup urine disease, tyrosinemia, cystic fibrosis, MCAD deficiency, severe combined immunodeficiency, toxoplasmosis. Newborns also undergo a hearing screening.
“The Final Report will cover the impact analysis of COVID-19 on this industry.”
Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10065034
Newborn screening tests cannot confirm or rule out diseases. They can only identify babies who may have a particular condition. This helps as follow up tests can be done which can give definitive results.
Market Dynamics
Due to increased awareness and improvement in technology the demand for newborn screening testing is increasing. Also due to increase in congenial heart defects the need for newborn screening is increasing. Government has also played a key factor in this matter due to increased funding. More and more physicians are also advising and pushing for newborn screening testing. However, growth is impeded due to lack of infrastructure, trained professional and socio-economic barriers.
Market Segmentation
The market is segmented on the basis of technology, product, test type and geography. Further sub divisions based on technology are tandem mass spectrometry, DNA based assay, enzyme, immune assay, electrophoresis, hearing screening technology, pulse oxymetry technology. Sub divisions of product are new-born disorder screening instruments, hearing screening devices, accessories, pulse oxymetry, regions and assay kits. On the basis of test type market has been divided into critical congenital heart disease test, hearing screening test and dry blood spot test.
Request To Download Sample of This Strategic Report: https://www.kennethresearch.com/sample-request-10065034
Regional/Geographic Analysis
North America dominates the global newborn screening market due to low healthcare cost. Newborn screening market is said to increase in Asia in the next five years. Both India and China are growing markets for newborn screening testing due to a large pool of patients and increasing healthcare expenditure.
Key Players
Apollo Cradle, Life Cell, March of Dimes, Baby’s First Test, Baby Genes are some of the key players in newborn screening testing. Other key players include AB Sciex LLC, Bio-Rad Laboratories, Agilent Technologies and Covidien PLC.
About Kenneth Research
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Contact Us
Kenneth Research
Email : [email protected]
Phone: +1 313 462 0609
